Omnicell, Inc. (NASDAQ:OMCL ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Kathleen Nemeth - Head of IR Randall Lipps - Chief Executive Officer Nchacha Etta - EVP an
Omnicell (OMCL) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.84 per share a year ago.
Investors are optimistic about Omnicell (OMCL) on its strong execution of strategies, disciplined cost management and revenue timing.
Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.
Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.
Omnicell, Inc. (NASDAQ:OMCL ) Q1 2023 Results Conference Call May 2, 2023 4:30 PM ET Company Participants Kathleen Nemeth - Head of IR Randall Lipps - Chief Executive Officer Scott Seidelmann - Execut
Omnicell (OMCL) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.83 per share a year ago.
Investors are optimistic about Omnicell (OMCL) owing to its planned geographic expansion.
Omnicell, Inc. (NASDAQ:OMCL ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Kathleen Nemeth - Senior Vice President, Investor Relations Randall Lipps - Founder, Ch
Omnicell (OMCL) delivered earnings and revenue surprises of 266.67% and 3.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Identifying toxic stocks and offloading them at the right time can help you avoid huge losses. OMCL, CCL, AY and TFSL are a few such toxic stocks that you should dump right away.

4 Toxic Stocks That May Not Let You Prosper

09:02am, Wednesday, 08'th Feb 2023
If you own toxic stocks for long, you are likely to see a big loss in your wealth. Stay away from toxic stocks like BALY, OMCL, AY and TFSL.
Omnicell has a record of volume growth but volatile profitability and is experiencing poor order visibility. Operating in a competitive market with the healthcare industry under pressure from rising c
Consider dumping toxic stocks like BALY, OMCL, ILMN and AY from your portfolio to avoid huge losses.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE